Literature DB >> 3810046

Epidemiological, bacteriological and complicating features of erysipelas.

C Jorup-Rönström.   

Abstract

233 patients with erysipelas, admitted to the Department of Infectious Diseases, Danderyd Hospital, during a 2-year period were analysed for epidemiological, bacteriological and complicating features. Erysipelas was defined clinically as a febrile skin infection with a sudden onset of a red indurated expanding plaque with a distinct border. Common predisposing factors were alcohol abuse, diabetes mellitus and venous insufficiency, and complications were more common among such patients. No seasonal variation was found. 5% of patients with blood culture had streptococcemia (7/149). Erysipelas emerging from an infected ulcer was seen in 52% (122/233) and in 46% of these streptococci were isolated (57/122), 67% of which were of type A (38/57). Staphylococcus aureus was isolated from 59% of ulcerative cases (72/122) and in 3 of them staphylococci were found in the blood.

Entities:  

Mesh:

Year:  1986        PMID: 3810046     DOI: 10.3109/00365548609021656

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  19 in total

1.  Risk factors for erysipelas of the leg (cellulitis): case-control study.

Authors:  A Dupuy; H Benchikhi; J C Roujeau; P Bernard; L Vaillant; O Chosidow; B Sassolas; J C Guillaume; J J Grob; S Bastuji-Garin
Journal:  BMJ       Date:  1999-06-12

2.  Red in the face: Make the diagnosis.

Authors:  M A Miller
Journal:  Can J Infect Dis       Date:  1999-11

3.  Upper airway obstruction due to erysipelas.

Authors:  B Guslits
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

4.  Virulence properties of erysipelas-associated group A streptococci.

Authors:  A Norrby; B Eriksson; M Norgren; C J Rönström; A C Sjöblom; K Karkkonen; S E Holm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

5.  Evidence of streptococcal origin of acute non-necrotising cellulitis: a serological study.

Authors:  M Karppelin; T Siljander; A-M Haapala; J Aittoniemi; R Huttunen; J Kere; J Vuopio; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-18       Impact factor: 3.267

6.  Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.

Authors:  Athena Ferreira; Mark J Bolland; Mark G Thomas
Journal:  Infection       Date:  2016-04-16       Impact factor: 3.553

7.  Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial.

Authors:  Philippe Bernard; Olivier Chosidow; Loïc Vaillant
Journal:  BMJ       Date:  2002-10-19

8.  Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis.

Authors:  Craig G Gunderson; Benjamin M Cherry; Ann Fisher
Journal:  J Gen Intern Med       Date:  2018-07-18       Impact factor: 5.128

9.  Skin concentrations of phenoxymethylpenicillin in patients with erysipelas.

Authors:  A C Sjöblom; J Bruchfeld; B Eriksson; C Jorup-Rönström; K Karkkonen; A S Malmborg; M Lindqvist
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

10.  Antibiotic prophylaxis in recurrent erysipelas.

Authors:  A C Sjöblom; B Eriksson; C Jorup-Rönström; K Karkkonen; M Lindqvist
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.